Perspectives on interleukin-2 immunotherapy for colon cancer.
Chang
A E
AE
D000818:Animals; D002087:Butyrates / Q000627:therapeutic use; D020148:Butyric Acid; D003110:Colonic Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D007167:Immunotherapy / Q000379:methods; D007376:Interleukin-2 / Q000627:therapeutic use*; D010534:Peritoneal Neoplasms / Q000276:immunology / Q000556:secondary / Q000628:therapy; D051381:Rats
D002087:Butyrates; D007376:Interleukin-2; D020148:Butyric Acid